
Survey of Third-Party Parenting Options Associated With Fertility Preservation Available to Patients With Cancer Around the Globe
2017; Lippincott Williams & Wilkins; Issue: 6 Linguagem: Inglês
10.1200/jgo.2017.009944
ISSN2687-8941
AutoresAlexandra S. Rashedi, Saskia F. de Roo, Lauren Ataman, Maxwell E. Edmonds, Adelino Amaral Silva, Aníbal Scarella, Anna Horbaczewska, Antoinette Anazodo, Ayşe Arvas, Bruno Ramalho de Carvalho, Cássio Sartório, C. C. M. Beerendonk, César Díaz‐García, Chang Suk Suh, Cláudia Melo, Claus Yding Andersen, E.L.A. Motta, Ellen Greenblatt, Ellen Van Moer, Elnaz Zand, Fernando M. Reis, F. Guerrero Sánchez, Guillermo Terrado, Jhenifer Kliemchen Rodrigues, João Marcos de Meneses e Silva, Johan Smitz, José V. Medrano, Jung Ryeol Lee, Katharina Winkler-Crepaz, Kristin Smith, Lígia Helena Ferreira Melo e Silva, L. Wildt, Mahmoud Salama, María del Mar Andrés, María T. Bourlon, Mario Vega, Maurício B. Chehin, Michel De Vos, Mohamed Khrouf, Nao Suzuki, Osama Azmy, Paula Fontoura, Paulo Henrique Almeida Campos-Júnior, Peter Mallmann, Ricardo Azambuja, Ricardo Mello Marinho, Richard A. Anderson, Robert Jach, Roberto de Azevedo Antunes, Rod T. Mitchell, Rouhollah Fathi, Satish Kumar Adiga, Seido Takae, Seok Hyun Kim, Sergio Romero, Silvana Chedid Grieco, Talya Shaulov, Tatsuro Furui, Teresa Almeida‐Santos, W. L. D. M. Nelen, Yasmin Jayasinghe, Yodo Sugishita, Teresa K. Woodruff,
Tópico(s)Assisted Reproductive Technology and Twin Pregnancy
ResumoPurpose In the accompanying article, “Survey of Fertility Preservation Options Available to Patients With Cancer Around the Globe,” we showed that specific fertility preservation services may not be offered at various sites around the world because of cultural and legal barriers. We assessed global and regional experiences as well as the legal status of third-party reproduction and adoption to serve as a comprehensive international data set and resource for groups that wish to begin oncofertility interventions. Methods We provide data on the legalities of third-party assisted reproductive technologies and other family-building options in the 28 oncofertility-practicing countries surveyed. Results We found regional and country differences that will be important in the development of tailored resources for physicians and for patient brochures that are sensitive to these local restrictions and cultural norms. Conclusion Because many patients first consult Web-based materials, the formal assessment of the availability of these options provides members of the global oncofertility community with data to which they might otherwise not have ready access to better serve their patients.
Referência(s)